ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice

Journal of Clinical Investigation

Volumn 122, Issue 3, 2012, Pages 833-843

  Casimiro, Mathew C ^a   Crosariol, Marco ^a   Loro, Emanuele ^a   Ertel, Adam ^a   Yu, Zuoren ^a   Dampier, William ^b   Saria, Elizabeth A ^c   Papanikolaou, Alex ^c   Stanek, Timothy J ^a   Li, Zhiping ^a   Wang, Chenguang ^a   Fortina, Paolo ^a   Addya, Sankar ^a   Tozeren, Aydin ^b   Knudsen, Erik S ^a   Arnold, Andrew ^c   Pestell, Richard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; IMMUNOFLUORESCENCE; IN VIVO STUDY; MAMMARY GLAND; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; SPECTRAL KARYOTYPING; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CYCLIN D1; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KARYOTYPING; MICE; MICE, TRANSGENIC; TRANSCRIPTION, GENETIC;

EID: 84863256545     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60256     Document Type: Article

References (63)

1. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9(3):153-166.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396(6712):643-649. (Pubitemid 29003936)
3. Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20(6):R285-295.
4. Gollin SM. Mechanisms leading to chromosomal instability. Semin Cancer Biol. 2005;15(1):33-42. (Pubitemid 40018526)
5. Draviam VM, Xie S, Sorger PK. Chromosome segregation and genomic stability. Curr Opin Genet Dev. 2004;14(2):120-125. (Pubitemid 38520138)
6. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297-300.
7. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006;38(9):1043-1048. (Pubitemid 44325930)
8. Mayhew CN, et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology. 2007;133(3):976-984. (Pubitemid 47374137)
9. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323-330.
10. Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphory lation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993;7(3):331-342. (Pubitemid 23139228)
11. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J-Y, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993;73(3):487-497. (Pubitemid 23143348)
12. Sakamaki T, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol. 2006;26(14):5449-5469. (Pubitemid 44036212)
13. Wang C, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A. 2006;103(31):11567-11572. (Pubitemid 44182492)
14. Stacey DW. Three observations that have changed our understanding of cyclin D1 and p27 in cell cycle control. Genes Cancer. 2010;1(12):1189-1199.
15. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev. 1999;20(4):501-534. (Pubitemid 30647078)
16. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology. 2004;145(12):5439-5447. (Pubitemid 39564581)
17. Fu M, et al. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem. 2005;280(17):16934-16941. (Pubitemid 41389153)
18. Keyomarsi K, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med. 2002;347(20):1566-1575. (Pubitemid 35315837)
19. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994;369(6482):669-671. (Pubitemid 24199473)
20. Sicinski P, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 1995;82(4):621-630.
21. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 2001;411(6841):1017-1021. (Pubitemid 32612319)
22. Hulit J, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol. 2004;24(17):7598-7611. (Pubitemid 39121486)
23. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 1997;88(3):405-415. (Pubitemid 27131382)
24. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 1998;12(22):3488-3498. (Pubitemid 28553241)
25. Reutens AT, et al. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol. 2001;15(5):797-811. (Pubitemid 32411317)
26. Fu M, et al. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem. 2005;280(33):29728- 29742. (Pubitemid 41177050)
27. Bienvenu F, Barre B, Giraud S, Avril S, Coqueret O. Transcriptional regulation by a DNA-associated form of cyclin D1. Mol Biol Cell. 2005;16(4):1850-1858. (Pubitemid 40471954)
28. Bienvenu F, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature. 2010;463(7279):374-378.
29. Wang C, et al. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res. 2005;65(15):6557-6567. (Pubitemid 41060691)
30. Zhou J, et al. Attenuation of Forkhead signaling by the retinal determination factor DACH1. Proc Natl Acad Sci U S A. 2010;107(15):6864-6869.
31. Yu Z, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol. 2008;182(3):509-517.
32. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32(database issue):D91-D94.
33. Hsu JY, et al. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell. 2000;102(3):279-291.
34. Giet R, Glover DM. Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. J Cell Biol. 2001;152(4):669-682.
35. Tatsuka M, et al. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 1998;58(21):4811-4816. (Pubitemid 28503674)
36. Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406(6796):641-645.
37. Ertel A, et al. RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle. 2010;9(20):4153-4163.
38. Hu Z, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96.
39. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer research. 2001;61(3):818-822. (Pubitemid 32174384)
40. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5(10):773-785. (Pubitemid 41400777)
41. Nelsen CJ, et al. Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem. 2005;280(1):768-776. (Pubitemid 40165045)
42. Aggarwal P, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev. 2007;21(22):2908-2922. (Pubitemid 350133439)
43. Del Rey J, et al. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors. BMC Cancer. 2010;10:280.
44. Jirstrom K, et al. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. Cancer Res. 2005;65(17):8009-8016. (Pubitemid 41297281)
45. Millar EK, et al. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene. 2009;28(15):1812-1820.
46. Manchado E, Malumbres M. Targeting aneuploidy for cancer therapy. Cell. 2011;144(4):465-466.
47. Tang YC, Williams BR, Siegel JJ, Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell. 2011;144(4):499-512.
48. Li Z, et al. Alternative cyclin d1 splice forms differentially regulate the DNA damage response. Cancer Res. 2010;70(21):8802-8811.
49. Jirawatnotai S, et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011;474(7350):230- 234.
50. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell. 1999;98(3):387-396. (Pubitemid 29380573)
51. Wendt KS, et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature. 2008;451(7180):796-801. (Pubitemid 351253176)
52. Rubio ED, et al. CTCF physically links cohesin to chromatin. Proc Natl Acad Sci U S A. 2008;105(24):8309-8314. (Pubitemid 351904752)
53. Li Z, et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol. 2006;26(11):4240-4256. (Pubitemid 43788023)
54. Wang C, et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol. 2003;23(17):6159-6173. (Pubitemid 37013094)
55. Labhart P, et al. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci U S A. 2005;102(5):1339-1344. (Pubitemid 40214365)
56. Bromberg JF, et al. Stat3 as an oncogene. Cell. 1999;98(3):295-303. (Pubitemid 29380565)
57. Lee RJ, et al. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem. 1999;274(11):7341-7350.
58. Wu K, et al. Cell fate determination factor Dachshund reprograms breast cancer stem cell function. J Biol Chem. 2011;286(3):2132-2142.
59. Macville M, et al. Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements. Histochem Cell Biol. 1997;108(4-5):299-305. (Pubitemid 27468130)
60. Barrett T, et al. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucl Acids Res. 2007;35(database issue):D760-D765.
61. Brazma A, et al. ArrayExpress - a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2003;31(1):68-71. (Pubitemid 36150335)
62. Silkworth WT, Nardi IK, Scholl LM, Cimini D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS One. 2009;4(8):e6564.
63. Li Z, et al. Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration. J Biol Chem. 2008;283(11):7007-7015.